Microparticles in deep venous thrombosis, antiphospholipid syndrome and Factor V Leiden

References

• George JN, Pickett EB, Saucerman S, McEver RP, Kunichi TJ, Kieffer N, Newman PJ. Platelet surface glycoproteins. Studies on resting and activated platelets and platelet membrane microparticles in normal subjects, and observations in patients during adult respiratory distress syndrome and cardiac surgery. J Clin Invest 1986; 78: 340–348
   PubMed Web of Science ®Google Scholar
• Berckmans RJ, Nieuwland R, Boing AN, Romijim FPHTM, Hack CE, Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001; 85: 639–646
   PubMed Web of Science ®Google Scholar
• Janiszewski M, Do Carmo AO, Pedro MA, Silva E, Knobel E, Laurindo FR. Platelet-derived exosomes of septic individuals possess proapoptotic NAD(P)H oxidase activity: A novel vascular redox pathway. Crit Care Med 2004; 3: 818–825
   Google Scholar
• Diamant M, Nieuwland R, Pablo RF, Sturk A, Smit JW, Radder JK. Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes. Circulation 2002; 106: 2442–2447
   PubMed Web of Science ®Google Scholar
• Nieuwland R, Berckmans RJ, Rotteveel-Eijkman RC, Maquelin KN, Roozendaal KJ, Jansen PG, ten Have K, Eijsman L, Hack CE, Sturk A. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation 1997; 96: 3534–3541
   PubMed Web of Science ®Google Scholar
• Mallat Z, Benamer H, Hugel B, Benessiano J, Steg PG, Freyssinet JM, Tedgui A. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000; 101: 841–843
   PubMed Web of Science ®Google Scholar
• Ando M, Iwata A, Ozeki Y, Tsuchiya K, Akiba T, Nihei H. Circulating platelet-derived microparticles with procoagulant activity may be a potential cause of thrombosis in uremic patients. Kidney Int 2002; 62: 1757–1763
   PubMedGoogle Scholar
• Holme PA, Solum NO, Brosstad F, Røger M, Abdelnoor M. Demonstration of platelet-derived microvesicles in blood from patients with activated coagulation and fibrinolysis using a filtration technique and western blotting. Thromb Haemost 1994; 5: 666–671
   Google Scholar
• Katopodis JN, Kolodny L, Jy W, Horstman LL, De Marchena EJ, Tao JG, Haynes DH, Ahn YS. Platelet microparticles and calcium homeostasis in acute coronary ischemias. Am J Hematol 1997; 2: 95–101
   Google Scholar
• Zeiger F, Stephan S, Hoheisel G, Pfeiffer D, Ruehlmann C, Koksch M. P-selectin expression, platelet aggregates, and platelet-derived microparticle formation are increased in peripheral arterial disease. Blood Coagul Fibrinolysis 2000; 8: 723–728
   Google Scholar
• Nomura S, Kanazawa S, Fukuhara S. Effects of eicosapentaenoic acid on platelet activation markers and cell adhesion molecules in hyperlipidemic patients with Type 2 diabetes mellitus. J Diab Compl 2003; 17: 153–159
   Google Scholar
• Warkentin TE, Hayward CP, Boshkov LK, Santos AV, Sheppard JA, Bode AP, Kelton JG. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: An explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood 1994; 11: 3691–3699
   Google Scholar
• Nomura S, Komiyama Y, Miyake T, Miyaki Y, Kido H, Suzuki M, Kagawa H, Yanabu M, Takahashi H, Fukuhara S. Amyloid beta-protein precursos-rich platelet microparticles in thrombotic disease. Thromb Haemost 1998; 72: 519–522
   Google Scholar
• Biró E, Sturk-Maquelin KN, Vogel GM, Meuleman DG, Smit MJ, Hack CE, Sturk A, Nieuwland R. Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. J Thromb Haemost 2003; 12: 2561–2568
   Google Scholar
• Kahn I, Zucker-Franklin D, Karpatkin S. Microthrombocytosis and platelet fragmentation associated with idiopathic/autoimmune thrombocytopenic purpura. Br J Haematol 1975; 31: 449–460
   Google Scholar
• Lee VJ, Horstman LL, Janania J, Reyes Y, Kelley RE, Ahn YS. Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multi-infarct dementias. Thomb Res 1993; 72: 295–304
   PubMed Web of Science ®Google Scholar
• Enjeti AK, Lincz LF, Seldon M. Detection and measurement of microparticles an evolving research tool for vascular biology. Semin Thromb Hemost 2007; 8: 771–779
   Google Scholar
• Heijboer H, Brandjes DPM, Büller HR, Sturk A, tem Cate JW. Deficiences of coagulation-inhibiting and fibrinolytic proteins in outpacients with deep-vein thrombosis. N Engl J Med 1990; 323: 1512–1516
   PubMed Web of Science ®Google Scholar
• Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the region of the prothrombin gene is associated with eleveted plasna prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698–3703
   PubMed Web of Science ®Google Scholar
• Rosendaal FR, Koster T, Vandenbroucke JP. Hight risk of thrombosis in patients homozigous for factor V Leiden (actived protein C resistance). Blood 1995; 85: 1504–1508
   PubMed Web of Science ®Google Scholar
• Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, DE Groot PG, Koike T, Meroni PL, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 2: 295–306
   Web of Science ®Google Scholar
• Nieuwland R, Berckmans RJ, McGregor S, Böing AN, Romijn FP, Westendorp RG, Hack CE, Sturk A. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 2000; 3: 930–935
   Google Scholar
• Arruda VR, Annichino-Bizzacchi JM, Costa FF, Reitsma PH. Factor V Leiden (FVQ506) is common in Brazilian population. Am J Hematol 1995; 49: 242–243
   Google Scholar
• Kessels H, Béguin S, Andree H, Hemker HC. Measurement of thrombin generation in whole blood. the effect of heparin and aspirin.Thromb Haemost 1994; 72: 78–83
   Google Scholar
• Erkan D, Yazici Y, Peterson MG, Sammaritano L, Lockshin MD. A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome. Rheumatology 2002; 41: 924–929
   PubMed Web of Science ®Google Scholar
• Lind SE, Callas PW, Golden EA, Joyner KA, Jr, Ortel TL. Plasma levels of factors II, VII and X and their relationship to the international normalized ratio during chronic warfarin therapy. Blood Coagul Fibrinolysis 1997; 8: 48–53
   PubMed Web of Science ®Google Scholar
• Sise HS, Lavelle SM, Adamis D, Becker R. Relation of hemorrhage and thrombosis to prothrombin during treatment with coumarin-type anticoagulants. N Engl J Med 1958; 259: 266–271
   PubMed Web of Science ®Google Scholar
• Zivelin A, Rao LV, Rapaport SI. Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K-dependent clotting factors. J Clin Invest 1993; 92: 2131–2140
   Web of Science ®Google Scholar
• Hurlen M, Abdelnoor M, Smith P, Erikssen J, Arnesen H. Warfarin, aspirin, or both after myocardial infarction. N Engl J Med 2002; 347: 969–974
   PubMed Web of Science ®Google Scholar
• van Es RF, Jonker JJ, Verheugt FW, Deckers JW, Grobbee DE. Aspirin and coumadin after acute coronary syndromes (the ASPECT–2 study): A randomised controlled trial. Lancet 2002; 360: 109–113
   PubMed Web of Science ®Google Scholar
• Choudhury A, Chung I, Blann AD, Gregory YH. Elevated platelet microparticle levels in nonvalvular atrial fibrillation: Relationship to P-selectin and antithrombotic therapy. Chest 2007; 131: 809–815
   PubMed Web of Science ®Google Scholar
• Messri M, Altieri DC. Endothelial cell activation by leukocyte microparticles. J Immunol 1998; 161: 4382–4387
   Google Scholar
• Mesri M, Altieri DC. Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in JNK1 signaling pathway. J Biol Chem 1999; 274: 23111–23118
   PubMed Web of Science ®Google Scholar
• Barry OP, Pratico D, Lawson JA, FitzGerald GA. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest 1997; 99: 2118–2127
   PubMed Web of Science ®Google Scholar
• Barry OP, Pratico D, Savani RC, FitzGerald GA. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest 1998; 102: 136–144
   PubMed Web of Science ®Google Scholar
• Barry OP, FitzGerald GA. Mechanisms of cellular activation by platelet microparticles. Thromb Haemost 1999; 82: 794–800
   PubMed Web of Science ®Google Scholar
• Boulanger CM, Scoazec A, Ebrahimian T, Henry P, Mathieu E, Tedgui A, Mallat Z. Circulation microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 2001; 104: 2649–2652
   PubMed Web of Science ®Google Scholar
• Joop K, Berckmans RJ, Nieuwland R, Berkhout J, Romijn FP, Hack CE, Sturk A. Microparticles in patients with multi-organ dysfunction syndrome and sepsis support coagulantion through multiple mechanisms. Thromb Haemost 2001; 85: 810–820
   PubMed Web of Science ®Google Scholar
• Rectenwald JE, Myers DD, Jr, Hawley AE, Longo C, Henke PK, Guire KE, Schmaier AH, Wakefield TW. D-dimer, P-selectin, and microparticles: Novel markers to predict deep venous thrombosis. A pilot study. Thromb Haemost 2005; 6: 1312–1317
   Google Scholar
• Chirinos JA, Heresi GA, Velasquez H, Jy W, Jimenez JJ, Ahn E, Horstman LL, Soriano AO, Zambrano JP, Ahn YS. Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol 2005; 9: 1467–1471
   Google Scholar
• Tesselaar ME, Romijn FP, Van Der Linden IK, Prins FA, Bertina RM, Osanto S. Microparticle-associated tissue factor activity: A link between cancer and thrombosis. J Thromb Haemost 2007; 3: 520–527
   Google Scholar
• Pereira J, Alfaro G, Goycoolea M, Quiroga T, Ocqueteau M, Massardo L, Pérez C, Sáez C, Panes O, Matus V, et al. Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state. Thromb Haemost 2006; 1: 94–99
   Google Scholar
• Hanson SR, Griffin JH, Harker LA, Kelly AB, Esmon CT, Gruber A. Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates. J Clin Invest 1993; 92: 2003–2212
   PubMed Web of Science ®Google Scholar
• Tans G, Rosing J, Thomassen MC, Heeb MJ, Zwaal RF, Griffin JH. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood 1991; 77: 2641–2648
   PubMed Web of Science ®Google Scholar
• Macfarlane RF, Biggs R. A thrombin generation test; the application in haemophilia and thrombocytopenia. J Clin Pathol 1953; 6: 3–8
   PubMed Web of Science ®Google Scholar
• Pitney WR, Dacie JV. A simple method of studying the generation of thrombin in recalcified plasma; application in the investigation of haemophilia. J Clin Pathol 1953; 6: 9–14
   PubMed Web of Science ®Google Scholar
• Hemker HC, Willems GM, Beguin S. A computer assisted method to obtain the prothrombin activation velocity in whole plasma independent of thrombin decay processes. Thromb Haemost 1986; 56: 9–17
   PubMed Web of Science ®Google Scholar
• Hemker H, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, Lecompte T, Beguin S. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33: 4–15
   PubMed Web of Science ®Google Scholar
• Freyssinet J-M, Dignat-George F. More on: Measuring circulating cell-derived microparticles. J Thromb Haemost 2005; 3: 613–614
   Google Scholar